CAR T-Cell Therapy Remains Underutilized, Despite Improvements in Access
Significant progress has been made since the approval of the first CAR T-cell therapy, but there is still tremendous room for improvement.
“Reunited, and It Feels So Good”: The ASCO Annual Meeting
The 2024 ASCO Annual Meeting was invigorating and inspired a renewed commitment to advancing cancer treatment.
